findmyKOL

Akshay Desai, MD

Enriched profile

Medical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusHeart Failure Treatment and Management+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2021–2026

Akshay Desai is Medical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 652 publications with 57,900 citations (h-index 102); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Akshay Desai, MD, is Medical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital. The public record shows 652 publications with 57,900 citations (h-index 102), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 28 companies, 2 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · Circulation. Heart failure
  • Top research focus: Heart Failure Treatment and Management
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 28 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure5 trialsType 2 Diabetes

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementCardiac pacing and defibrillation studiesHormonal Regulation and Hypertension

Drugs & molecules

across trials, industry payments and publications
Farxigageneric · DapagliflozinClinical trials—Industry payments2Publications14Kerendiageneric · FinerenoneClinical trials—Industry payments5Publications9Verquvogeneric · VericiguatClinical trials—Industry payments6Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments4Publications—Furoscixgeneric · FurosemideClinical trials—Industry payments2Publications—Lokelmageneric · Sodium zirconium cyclosilicateClinical trials—Industry payments2Publications—Jaypircageneric · PirtobrutinibClinical trials—Industry payments1Publications—Verzeniogeneric · AbemaciclibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbott LaboratoriesClinical trials—Industry payments47Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments33Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments15Merck Sharp & Dohme LLCClinical trials—Industry payments8AstraZeneca UK LimitedClinical trials—Industry payments5Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments5GlaxoSmithKline, LLC.Clinical trials—Industry payments5AstraZeneca Pharmaceuticals LPClinical trials—Industry payments4Novartis Pharmaceuticals CorporationClinical trials—Industry payments4AstraZeneca ABClinical trials—Industry payments3Boston Scientific CorporationClinical trials—Industry payments3Endotronix, Inc.Clinical trials—Industry payments3Medtronic, Inc.Clinical trials—Industry payments3Brigham and Women's HospitalClinical trials2Industry payments—F. Hoffmann-La Roche AGClinical trials—Industry payments2Northwestern UniversityClinical trials2Industry payments—Scpharmaceuticals Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments1Anumana, Inc.Clinical trials—Industry payments1Biofourmis Inc.Clinical trials1Industry payments—Dr.Reddy's Laboratories,Inc.Clinical trials—Industry payments1iRhythm Technologies, Inc.Clinical trials—Industry payments1Lilly USA, LLCClinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1Novartis Pharma AGClinical trials—Industry payments1Novo Nordisk IncClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1Roche Diagnostics International LtdClinical trials—Industry payments1Volta Medical IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
652publications

Distinct works indexed by OpenAlex, matched via ORCID; 47 in PubMed.

57,900citations

Total citations across indexed works.

102h-index

Hirsch index (OpenAlex). i10-index 350.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
28companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    76.1%
    Beta blocker17%
    Metoprolol Succinate71%Carvedilol21%Atenolol4%Sotalol4%
    Part D<11 patients
    Statin14.7%
    Atorvastatin Calcium68%Rosuvastatin Calcium27%Pravastatin Sodium6%
    Part D<11 patients

    + 13 more classes in this area

  • Metabolism & gastrointestinal

    11.7%
    SGLT2 inhibitor9.8%
    Jardiance53%Farxiga42%Dapagliflozin5%
    Part D<11 patients
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    8.9%
    Factor Xa inhibitor7.4%
    Eliquis79%Xarelto21%
    Part D≥42 patients
    P2Y12 inhibitor1.4%
    Clopidogrel100%
    Part D≥12 patients
All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)88.5% facility · 11.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

Congress activity

Updated 16 Oct 2026

1 congress contribution (2020) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Scott D. Solomon389John J.V. McMurray329Brian Claggett244Pardeep S. Jhund218Michael R. Zile176Muthiah Vaduganathan173Jean L. Rouleau160Milton Packer126Marc A. Pfeffer125Sanjiv J. Shah116Carolyn S.P. Lam106Felipe A. Martínez95Inder S. Anand93Martin Lefkowitz91Mikhail Kosiborod89Lars Køber88Karl Swedberg86Eldrin F. Lewis81Silvio E. Inzucchi75Adrian F. Hernandez75Rudolf A. de Boer74Anna Maria Langkilde63Orly Vardeny59Eileen O’Meara59Lynne W. Stevenson59Victor Shi59Faı̈ez Zannad55Bertram Pitt47Kieran F. Docherty43Magnus Petersson43Toru Kondo40William T. Abraham39Marc S. Sabatine38James C. Fang37Mark C. Petrie36Piotr Ponikowski35Jawad H. Butt35Mandeep R. Mehra32Michael M. Givertz31Nancy K. Sweitzer30

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/akshay-desai-007251a

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Akshay-S-Desai-2210431860

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    hfsa.org/akshay-s-desai-md-mph-fhfsa

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/the-lead-podcast-episode-53/id1696126287

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • Other

    jacc.org/journal/heart-failure/podcasts

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chair

    HFSA Annual Scientific Meeting (ASM) 2023 Program Committee

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Deputy Editor

    JACC: Heart Failure

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗
  • Fellow

    Heart Failure Society of America (FHFSA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.